These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10579310)

  • 1. Postnatal growth responses to insulin-like growth factor I in insulin receptor substrate-1-deficient mice.
    Pete G; Fuller CR; Oldham JM; Smith DR; D'Ercole AJ; Kahn CR; Lund PK
    Endocrinology; 1999 Dec; 140(12):5478-87. PubMed ID: 10579310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficient expression of insulin receptor substrate-1 (IRS-1) fails to block insulin-like growth factor-I (IGF-I) stimulation of brain growth and myelination.
    Ye P; Li L; Lund PK; D'Ercole AJ
    Brain Res Dev Brain Res; 2002 Jun; 136(2):111-21. PubMed ID: 12101028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-specific effects of insulin receptor substrate-1 deficiency on normal and IGF-I-mediated colon growth.
    Simmons JG; Ling Y; Wilkins H; Fuller CR; D'Ercole AJ; Fagin J; Lund PK
    Am J Physiol Gastrointest Liver Physiol; 2007 Nov; 293(5):G995-1003. PubMed ID: 17823215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administration of growth hormone (GH), but not insulin-like growth factor-I (IGF-I), by continuous infusion can induce the formation of the 150-kilodalton IGF-binding protein-3 complex in GH-deficient rats.
    Gargosky SE; Tapanainen P; Rosenfeld RG
    Endocrinology; 1994 May; 134(5):2267-76. PubMed ID: 7512499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of the pleckstrin and phosphotyrosine binding domains of insulin receptor substrate-2 does not impair its ability to regulate cell proliferation in myeloid cells.
    Sun H; Baserga R
    Endocrinology; 2004 Nov; 145(11):5332-43. PubMed ID: 15297443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of insulin-like growth factor signaling pathways in mammary gland by pure antiestrogen ICI 182,780.
    Chan TW; Pollak M; Huynh H
    Clin Cancer Res; 2001 Aug; 7(8):2545-54. PubMed ID: 11489838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiinsulin receptor autoantibodies induce insulin receptors to constitutively associate with insulin receptor substrate-1 and -2 and cause severe cell resistance to both insulin and insulin-like growth factor I.
    Auclair M; Vigouroux C; Desbois-Mouthon C; Deibener J; Kaminski P; Lascols O; Cherqui G; Capeau J; Caron M
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3197-206. PubMed ID: 10487687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of oral administration of insulin-like growth factor-I on circulating concentration of insulin-like growth factor-I and growth of internal organs in weanling mice.
    Kim WK; Ryu YH; Seo DS; Lee CY; Ko Y
    Biol Neonate; 2006; 89(3):199-204. PubMed ID: 16293962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo.
    Lee AV; Jackson JG; Gooch JL; Hilsenbeck SG; Coronado-Heinsohn E; Osborne CK; Yee D
    Mol Endocrinol; 1999 May; 13(5):787-96. PubMed ID: 10319328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene.
    Araki E; Lipes MA; Patti ME; Brüning JC; Haag B; Johnson RS; Kahn CR
    Nature; 1994 Nov; 372(6502):186-90. PubMed ID: 7526222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary control of growth in the neonatal rat: effects of neonatal hypophysectomy on somatic and organ growth, serum insulin-like growth factors (IGF)-I and -II levels, and expression of IGF binding proteins.
    Glasscock GF; Gelber SE; Lamson G; McGee-Tekula R; Rosenfeld RG
    Endocrinology; 1990 Oct; 127(4):1792-803. PubMed ID: 1698146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postnatally elevated levels of insulin-like growth factor (IGF)-II fail to rescue the dwarfism of IGF-I-deficient mice except kidney weight.
    Moerth C; Schneider MR; Renner-Mueller I; Blutke A; Elmlinger MW; Erben RG; Camacho-Hübner C; Hoeflich A; Wolf E
    Endocrinology; 2007 Jan; 148(1):441-51. PubMed ID: 17008389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inability of overexpressed des(1-3)human insulin-like growth factor I (IGF-I) to inhibit forced mammary gland involution is associated with decreased expression of IGF signaling molecules.
    Hadsell DL; Alexeenko T; Klimentidis Y; Torres D; Lee AV
    Endocrinology; 2001 Apr; 142(4):1479-88. PubMed ID: 11250928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of 14-day infusions of growth hormone and/or insulin-like growth factor I on the obesity of growing Zucker rats.
    Dubuis JM; Deal C; Tsagaroulis P; Clark RG; Van Vliet G
    Endocrinology; 1996 Jul; 137(7):2799-806. PubMed ID: 8770900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of insulin-like growth factor-binding protein-4 (IGFBP-4) in smooth muscle cells of transgenic mice through a smooth muscle alpha-actin-IGFBP-4 fusion gene induces smooth muscle hypoplasia.
    Wang J; Niu W; Witte DP; Chernausek SD; Nikiforov YE; Clemens TL; Sharifi B; Strauch AR; Fagin JA
    Endocrinology; 1998 May; 139(5):2605-14. PubMed ID: 9564877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IGF-I receptor protection from apoptosis in cells lacking the IRS proteins.
    Dews M; Nishimoto I; Baserga R
    Recept Signal Transduct; 1997; 7(4):231-40. PubMed ID: 9633824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced growth of small bowel in transgenic mice expressing human insulin-like growth factor I.
    Ohneda K; Ulshen MH; Fuller CR; D'Ercole AJ; Lund PK
    Gastroenterology; 1997 Feb; 112(2):444-54. PubMed ID: 9024298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth allometry of organs, muscles and bones in mice from lines divergently selected on the basis of plasma insulin-like growth factor-I.
    Siddiqui RA; McCutcheon SN; Blair HT; Mackenzie DD; Morel PC; Breier BH; Gluckman PD
    Growth Dev Aging; 1992; 56(1):53-60. PubMed ID: 1601577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1.
    Tamemoto H; Kadowaki T; Tobe K; Yagi T; Sakura H; Hayakawa T; Terauchi Y; Ueki K; Kaburagi Y; Satoh S
    Nature; 1994 Nov; 372(6502):182-6. PubMed ID: 7969452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human insulin-like growth factor (IGF) binding protein-1 inhibits IGF-I-stimulated body growth but stimulates growth of the kidney in snell dwarf mice.
    Van Buul-Offers SC; Van Kleffens M; Koster JG; Lindenbergh-Kortleve DJ; Gresnigt MG; Drop SL; Hoogerbrugge CM; Bloemen RJ; Koedam JA; Van Neck JW
    Endocrinology; 2000 Apr; 141(4):1493-9. PubMed ID: 10746655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.